Literature DB >> 32152486

Peridiagnostic and cascade cancer genetic testing.

Nora Pashayan1, Clare Turnbull2,3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32152486     DOI: 10.1038/s41571-020-0348-4

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   65.011


× No keyword cloud information.
  2 in total

1.  Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia.

Authors:  Noelle V Frey; Saar Gill; Elizabeth O Hexner; Stephen Schuster; Sunita Nasta; Alison Loren; Jakub Svoboda; Edward Stadtmauer; Daniel J Landsburg; Anthony Mato; Bruce L Levine; Simon F Lacey; Jan Joseph Melenhorst; Elizabeth Veloso; Avery Gaymon; Edward Pequignot; Xinhe Shan; Wei-Ting Hwang; Carl H June; David L Porter
Journal:  J Clin Oncol       Date:  2020-04-16       Impact factor: 44.544

2.  Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening.

Authors:  Kenneth Offit; Kaitlyn A Tkachuk; Zsofia K Stadler; Michael F Walsh; Hector Diaz-Zabala; Jeffrey D Levin; Zoe Steinsnyder; Vignesh Ravichandran; Ravi N Sharaf; Melissa K Frey; Steven M Lipkin; Mark E Robson; Jada G Hamilton; Joseph Vijai; Semanti Mukherjee
Journal:  J Clin Oncol       Date:  2020-01-10       Impact factor: 50.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.